Effects of Hold Relax With Agonist Contraction and Active Release Therapy on Clinical Outcomes in Piriformis Syndrome

NCT ID: NCT05370378

Last Updated: 2023-04-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

82 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-02-22

Study Completion Date

2022-11-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to compare the effects of hold relax agonist contraction and active release therapy on reducing pain intensity, improving functioning and sleep quality in patient with piriformis syndrome.

Both these techniques are passive, non-invasive manual therapy techniques which are easy to perform and less time consuming and may yield better outcomes resulting improved quality of life.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Piriformis Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Group A: Hold Relax with Agonist Contraction with Routine Physical Therapy Group B: Active Release Therapy with Routine Physical Therapy
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
Opaque Sealed Envelops will be provided to participants by investigator, with mentioned treatment group. A separate therapist serving as outcome assessor will be unaware of treatment group provided.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

This group of participants will receive Hold Relax with Agonist Contraction (HR-AC) technique with routine physical therapy. The protocol will be given to the participants for two weeks (6 sessions on alternate days, 3 session per week). Each session will be of 60 minutes. The data will be collected before applying intervention, at first week and at 2nd week.

Group Type EXPERIMENTAL

Hold Relax with Agonist Contraction

Intervention Type OTHER

1. Participant will be in prone lying and heating pad will be applied on gluteal region for 10 to 15 minutes.
2. Passive sustained stretch to piriformis will be applied for 10 seconds.
3. The participant will be asked to actively contract the muscle for about 10 seconds (isometric contraction) and then relax.
4. Immediately after that participant is ask to again actively contract the muscle against therapist resistance for 6-10 seconds.
5. Ask the participant to relax while therapist will apply stretch the muscle to its new tissue tension barrier position and this position will be maintained for 30 seconds.
6. This maneuver is repeated for 3 to 4 repetitions, each starting from where the previous finished.

Group B

This group of participants will receive Active Release Therapy, a kind of soft tissue mobilization along with routine physical therapy. The protocol will be given to the participants for two weeks (6 sessions on alternate days, 3 session per week). Each session will be of 60 minutes. The data will be collected before applying intervention, at first week and at 2nd week.

Group Type ACTIVE_COMPARATOR

Active Release Therapy

Intervention Type OTHER

1. Specific muscle will be warmed up by applying heating pad for 10 to 15 minutes.
2. Patient will be positioned prone lying and the therapist will be standing at the side of affected limb.
3. Therapist will apply deep pressure at the area of tenderness while patient will actively move the limb from internal to external rotation repeatedly.
4. This maneuver will take about 15 minutes to complete in one session and will be applied alternatively 3 days a week for two weeks.
5. After this, cold pack is applied and general ROMs and strengthening exercises are performed to prevent soreness

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hold Relax with Agonist Contraction

1. Participant will be in prone lying and heating pad will be applied on gluteal region for 10 to 15 minutes.
2. Passive sustained stretch to piriformis will be applied for 10 seconds.
3. The participant will be asked to actively contract the muscle for about 10 seconds (isometric contraction) and then relax.
4. Immediately after that participant is ask to again actively contract the muscle against therapist resistance for 6-10 seconds.
5. Ask the participant to relax while therapist will apply stretch the muscle to its new tissue tension barrier position and this position will be maintained for 30 seconds.
6. This maneuver is repeated for 3 to 4 repetitions, each starting from where the previous finished.

Intervention Type OTHER

Active Release Therapy

1. Specific muscle will be warmed up by applying heating pad for 10 to 15 minutes.
2. Patient will be positioned prone lying and the therapist will be standing at the side of affected limb.
3. Therapist will apply deep pressure at the area of tenderness while patient will actively move the limb from internal to external rotation repeatedly.
4. This maneuver will take about 15 minutes to complete in one session and will be applied alternatively 3 days a week for two weeks.
5. After this, cold pack is applied and general ROMs and strengthening exercises are performed to prevent soreness

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Proprioceptive Neuromuscular Facilitation Technique Soft Tissue Mobilization

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age group 25-55 years
2. Both male and female.
3. Gluteal pain with or without radicular symptoms.
4. Patients of piriformis syndrome diagnosed by orthopedic consultant.
5. Sub-acute and chronic piriformis syndrome.
6. Unilateral pain.
7. Pain score equal to and greater than 3 according to pain rating scale.

Exclusion Criteria

1. Intermittent vascular claudication and spondylolisthesis.
2. Past history of hip, femur or vertebral fracture
3. Past history of spinal surgery.
4. Spinal tuberculosis.
5. Rheumatoid disease.
6. Disc pathology, sacroiliac joint dysfunction or mechanical back pain.
7. History of infectious disease.
8. Leg length discrepancy.
9. Any postural abnormality or deformity.
Minimum Eligible Age

25 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Lahore

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ayesha Jamil

Dr. Ayesha Jamil

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ayesha Jamil, M.Phil

Role: STUDY_CHAIR

University of Lahore

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The University of Lahore

Lahore, Punjab Province, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Nimra Ilyas

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.